Market Tracker

07/03 4:45pm ET

Regulus Therapeutics Inc (NASDAQ:RGLS)

10.20
Delayed Data
As of Jul 02
 -0.34 / -3.23%
Today’s Change
6.13
Today|||52-Week Range
25.60
-36.41%
Year-to-Date

Today’s Trading

Previous close10.54
Today’s open10.56
Day’s range10.05 - 10.82
Volume648,785
Average volume (3 months)739,407
Market cap$519.8M
Dividend yield--
Data as of 4:00pm ET, 07/02/2015

Growth & Valuation

Earnings growth (last year)-163.27%
Earnings growth (this year)+16.17%
Earnings growth (next 5 years)--
Revenue growth (last year)-60.81%
P/E ratioNM
Price/Sales92.22
Price/Book3.78

Competitors

 Today’s
change
Today’s
% change
INFIInfinity Pharmaceuti...+0.31+3.00%
VNDAVanda Pharmaceutical...+0.08+0.64%
MRTXMirati Therapeutics ...-0.39-1.23%
VTLVital Therapies Inc-0.78-3.57%
Data as of 4:00pm ET, 07/02/2015

Financials

Next reporting dateAugust 5, 2015
EPS forecast (this quarter)-$0.28
Annual revenue (last year)$7.7M
Annual profit (last year)-$56.7M
Net profit margin-739.08%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Paul C. Grint
CFO, Secretary, CAO &
General Counsel
David L. Szekeres
Corporate headquarters
San Diego, California

Forecasts